165 related articles for article (PubMed ID: 9390038)
1. New monoclonal antibodies to oestrogen and progesterone receptors effective for paraffin section immunohistochemistry.
Bevitt DJ; Milton ID; Piggot N; Henry L; Carter MJ; Toms GL; Lennard TW; Westley B; Angus B; Horne CH
J Pathol; 1997 Oct; 183(2):228-32. PubMed ID: 9390038
[TBL] [Abstract][Full Text] [Related]
2. Rabbit monoclonal antibodies show higher sensitivity than mouse monoclonals for estrogen and progesterone receptor evaluation in breast cancer by immunohistochemistry.
Rocha R; Nunes C; Rocha G; Oliveira F; Sanches F; Gobbi H
Pathol Res Pract; 2008; 204(9):655-62. PubMed ID: 18565685
[TBL] [Abstract][Full Text] [Related]
3. Estimation of hormone receptor status in fine-needle aspirates and paraffin-embedded sections from breast cancer using the novel rabbit monoclonal antibodies SP1 and SP2.
Cano G; Milanezi F; Leitão D; Ricardo S; Brito MJ; Schmitt FC
Diagn Cytopathol; 2003 Oct; 29(4):207-11. PubMed ID: 14506673
[TBL] [Abstract][Full Text] [Related]
4. Immunohistochemical detection of estrogen and progesterone receptors performed with an antigen-retrieval technique on methacarn-fixed paraffin-embedded breast cancer tissues.
Oyaizu T; Arita S; Hatano T; Tsubura A
J Surg Res; 1996 Jan; 60(1):69-73. PubMed ID: 8592434
[TBL] [Abstract][Full Text] [Related]
5. Gene expression of estrogen receptor, progesterone receptor and microtubule-associated protein Tau in high-risk early breast cancer: a quest for molecular predictors of treatment benefit in the context of a Hellenic Cooperative Oncology Group trial.
Pentheroudakis G; Kalogeras KT; Wirtz RM; Grimani I; Zografos G; Gogas H; Stropp U; Pectasides D; Skarlos D; Hennig G; Samantas E; Bafaloukos D; Papakostas P; Kalofonos HP; Pavlidis N; Fountzilas G
Breast Cancer Res Treat; 2009 Jul; 116(1):131-43. PubMed ID: 18668363
[TBL] [Abstract][Full Text] [Related]
6. Immunohistochemical evaluation of estrogen and progesterone receptors in paraffin-embedded, formalin-fixed endometrial tissues: comparison with enzyme immunoassay and immunohistochemical analysis of frozen tissue.
Ravn V; Havsteen H; Thorpe SM
Mod Pathol; 1998 Aug; 11(8):709-15. PubMed ID: 9720497
[TBL] [Abstract][Full Text] [Related]
7. Evaluation of seven oestrogen receptor beta antibodies for immunohistochemistry, western blotting, and flow cytometry in human breast tissue.
Skliris GP; Parkes AT; Limer JL; Burdall SE; Carder PJ; Speirs V
J Pathol; 2002 Jun; 197(2):155-62. PubMed ID: 12015738
[TBL] [Abstract][Full Text] [Related]
8. Estrogen receptor immunocytochemistry in paraffin embedded tissues with ER1D5 predicts breast cancer endocrine response more accurately than H222Sp gamma in frozen sections or cytosol-based ligand-binding assays.
Pertschuk LP; Feldman JG; Kim YD; Braithwaite L; Schneider F; Braverman AS; Axiotis C
Cancer; 1996 Jun; 77(12):2514-9. PubMed ID: 8640700
[TBL] [Abstract][Full Text] [Related]
9. Comparison of two antibodies for evaluation of estrogen receptors in paraffin-embedded tumors.
Hendricks JB; Wilkinson EJ
Mod Pathol; 1993 Nov; 6(6):765-70. PubMed ID: 7508117
[TBL] [Abstract][Full Text] [Related]
10. An ER activity profile including ER, PR, Bcl-2 and IGF-IR may have potential as selection criterion for letrozole or tamoxifen treatment of patients with advanced breast cancer.
Henriksen KL; Rasmussen BB; Lykkesfeldt AE; Møller S; Ejlertsen B; Mouridsen HT
Acta Oncol; 2009; 48(4):522-31. PubMed ID: 19173092
[TBL] [Abstract][Full Text] [Related]
11. Differences in oestrogen and progesterone receptors, HER-2, p53 expression and proliferation in ductal breast cancers in relation to histopathological grade.
Zasławski R; Surowiak P; Paluchowski P; Dziegiel P; Maciejczyk A; Pudełko M; Wojnar A; Zabel M
Folia Morphol (Warsz); 2005 Feb; 64(1):9-15. PubMed ID: 15832264
[TBL] [Abstract][Full Text] [Related]
12. Rapid and prognostically valid quantification of immunohistochemical reactions by immunohistometry of the most positive tumour focus. A prospective follow-up study on breast cancer using antibodies against MIB-1, PCNA, ER, and PR.
Biesterfeld S; Klüppel D; Koch R; Schneider S; Steinhagen G; Mihalcea AM; Schröder W
J Pathol; 1998 May; 185(1):25-31. PubMed ID: 9713356
[TBL] [Abstract][Full Text] [Related]
13. Oestrogen and progesterone receptors in Nigerian breast cancer: relationship to tumour histopathology and survival of patients.
Ikpatt OF; Ndoma-Egba R
Cent Afr J Med; 2003; 49(11-12):122-6. PubMed ID: 15301464
[TBL] [Abstract][Full Text] [Related]
14. Prognostic and predictive value of centrally reviewed expression of estrogen and progesterone receptors in a randomized trial comparing letrozole and tamoxifen adjuvant therapy for postmenopausal early breast cancer: BIG 1-98.
Viale G; Regan MM; Maiorano E; Mastropasqua MG; Dell'Orto P; Rasmussen BB; Raffoul J; Neven P; Orosz Z; Braye S; Ohlschlegel C; Thürlimann B; Gelber RD; Castiglione-Gertsch M; Price KN; Goldhirsch A; Gusterson BA; Coates AS
J Clin Oncol; 2007 Sep; 25(25):3846-52. PubMed ID: 17679725
[TBL] [Abstract][Full Text] [Related]
15. Re-evaluating adjuvant breast cancer trials: assessing hormone receptor status by immunohistochemical versus extraction assays.
Regan MM; Viale G; Mastropasqua MG; Maiorano E; Golouh R; Carbone A; Brown B; Suurküla M; Langman G; Mazzucchelli L; Braye S; Grigolato P; Gelber RD; Castiglione-Gertsch M; Price KN; Coates AS; Goldhirsch A; Gusterson B;
J Natl Cancer Inst; 2006 Nov; 98(21):1571-81. PubMed ID: 17077359
[TBL] [Abstract][Full Text] [Related]
16. Is triple negative a prognostic factor in breast cancer?
Nishimura R; Arima N
Breast Cancer; 2008; 15(4):303-8. PubMed ID: 18369692
[TBL] [Abstract][Full Text] [Related]
17. Estrogen and progesterone receptor expression and proliferation in breast cancer cells, studied with flow cytometry.
Scheres HM; Schutte B; De Goij AF; Bosman FT
Acta Histochem Suppl; 1990; 40():71-6. PubMed ID: 2091049
[No Abstract] [Full Text] [Related]
18. Development of new rabbit monoclonal antibody to progesterone receptor (Clone SP2): no heat pretreatment but effective for paraffin section immunohistochemistry.
Huang Z; Zhu W; Meng Y; Xia H
Appl Immunohistochem Mol Morphol; 2006 Jun; 14(2):229-33. PubMed ID: 16785796
[TBL] [Abstract][Full Text] [Related]
19. Expression of estrogen and progesterone receptors in non-small-cell lung cancer: immunohistochemical study.
Su JM; Hsu HK; Chang H; Lin SL; Chang HC; Huang MS; Tseng HH
Anticancer Res; 1996; 16(6B):3803-6. PubMed ID: 9042261
[TBL] [Abstract][Full Text] [Related]
20. Chemoendocrine compared with endocrine adjuvant therapies for node-negative breast cancer: predictive value of centrally reviewed expression of estrogen and progesterone receptors--International Breast Cancer Study Group.
Viale G; Regan MM; Maiorano E; Mastropasqua MG; Golouh R; Perin T; Brown RW; Kovács A; Pillay K; Ohlschlegel C; Braye S; Grigolato P; Rusca T; Gelber RD; Castiglione-Gertsch M; Price KN; Goldhirsch A; Gusterson BA; Coates AS
J Clin Oncol; 2008 Mar; 26(9):1404-10. PubMed ID: 18349391
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
